Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Once scar tissues mature, it is impossible for the surrounding tissue to regenerate normal dermal tissue. Therefore, it is essential to understand the fundamental mechanisms and establish effective strategies to inhibit aberrant scar formation. Hypertrophic scar formation is considered a result of the imbalance between extracellular matrix synthesis and degradation during wound healing. However, the underlying mechanisms of hypertrophic scar development are poorly understood. The purpose of this review was to outline the management in the early stage after wound healing to prevent hypertrophic scar formation, focusing on strategies excluding therapeutic agents of internal use. Treatment aimed at molecular targets, including cytokines, will be future options to prevent and treat hypertrophic scars. More basic studies and clinical trials, including combination therapy, are required to investigate the mechanisms and prevent hypertrophic scar formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gauglitz, G. G., Korting, H. C., Pavicic, T., Ruzicka, T., & Jeschke, M. G. (2011) · Molecular Medicine · doi:10.2119/molmed.2009.00153 · Cited by 1,462
Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977 · cited 1×
“This is why IL-10 downregulates the collagen expression in fibroblasts, leading to the attenuation of fibrosis [72,73].”
BackgroundBrown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., & van de Water, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1375 · Cited by 878 · cited 1×
“During the proliferation phase, abundant vascularization and angiogenesis play a key role in supplying the inflammatory cells and fibroblasts for the formation of an occasional granulation matrix [15].”
BackgroundThe role of myofibroblasts in wound healing
Hinz, B. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.003 · Cited by 328
Shi, J., Li, J., Guan, H., Cai, W., Bai, X., Fang, X., Hu, X., Wang, Y., Wang, H., Zheng, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098228 · Cited by 116
Cited by
Human Wound and Its Burden: Updated 2020 Compendium of Estimates
Sen, C. K. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0026 · Cited by 1,017
Human Wound and Its Burden: Updated 2022 Compendium of Estimates
Sen, C. K. (2023) · Advances in Wound Care · doi:10.1089/wound.2023.0150 · Cited by 360
Li, H., Li, B., Lv, D., Li, W., Lu, Y., & Luo, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114778 · Cited by 142
Yang, J., Huang, Z., Tan, J., Pan, J., Chen, S., & Wan, W. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.005 · Cited by 83
“Moreover, such anti-inflammatory and anti-oxidative strategies can reduce scar formation and improve healing quality [6,7].”
BackgroundPropolis compound inhibits profibrotic TGF-β1/SMAD signalling in human fibroblasts
Randall, L. J., Bajan, S., Tran, T. D., Harvey, R. J., & Russell, F. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-07918-2 · Cited by 9
“HS tends to regress within 1 to 2 years; however, once mature, regeneration of normal tissue does not occur 4 .”
Metadata
- Authors
- Shirakami, E., Yamakawa, S., & Hayashida, K.
- Venue
- Burns & Trauma
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-01-01
- Volume
- 8
- Pages
- tkz003-tkz003
- ISSN
- 2321-3868 (ISSN-L)
- 2321-3876
- OpenAlex
- W3003600713
- Cited by
- 131
- References
- 5
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence. https://app.cochat.ai/papers/10.1093/burnst/tkz003
- The paper
- Shirakami, E., Yamakawa, S., & Hayashida, K. (2020). Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence. Burns & Trauma. https://doi.org/10.1093/burnst/tkz003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.